Psychopharmacology

, Volume 106, Issue 1, pp 127–130 | Cite as

Effect of peripheral administration of cinnarizine and verapamil on the abstinence syndrome in diazepam-dependent rats

  • Yati Chugh
  • N. Saha
  • A. Sankaranarayanan
  • P. L. Sharma
Original Investigations

Abstract

The effects of two calcium channel blockers (verapamil and cinnarizine) were evaluated on diazepam withdrawal symptoms. Rats were made diazepam dependent by chronic treatment with daily injections of the drug, 20 mg/kg IP for 3 weeks. On abrupt termination of the drug, animals showed withdrawal hyperactivity that was assessed by autonomic, behavioural and motor signs. The peak effect was seen 3 days after the withdrawal of diazepam. On IP administration, verapamil and cinnarizine (10, 20 and 40 mg/kg) given on eight occasions at an interval of 12 h reversed the withdrawal-induced increase in spontaneous motor activity. Cinnarizine in higher doses (20 and 40 mg/kg) was found to be effective in suppressing the behavioural signs but verapamil did not show any protective effect against startle response and irritability. These results suggest that modulation of the calcium influx in the CNS might influence withdrawal.

Key words

Verapamil Cinnarizine Diazepam Withdrawal hyperactivity Rat 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Baeyens JM, Esposito E, Ossowaska E, Ossowaska G, Samanin R (1987) Effects of peripheral and central administration of calcium channel blockers in the naloxone-precipitated abstinence syndrome in morphine-dependent rats. Eur J Pharmacol 137:9–13Google Scholar
  2. Dolin SJ, Patch TL, Rabbani M, Siarey RJ, Bowhay AR, Little HJ (1990) Nitrendipine decreases benzodiazepine withdrawal seizures but not the development of benzodiazepine tolerance or withdrawal signs. Br J Pharmacol 101:691–697Google Scholar
  3. Godfraind T, Govoni S (1989) Increasing complexity revealed in regulation of Ca2+ antagonist receptor. TIPS 10:297–301Google Scholar
  4. Harris RA, Loh HH, Way EL (1976) Antinociceptive effects of lanthanum and cerium in nontolerant and morphine, tolerant-dependent animals. J Pharmacol Exp Ther 196:288–298Google Scholar
  5. Hitchcott PK, Zharkovsky A, File SE (1990) Acute CGS8216 reverses and concurrent verapamil prevents, diazepam withdrawal-induced anxiety in rats. Br J Pharmacol 100:354PGoogle Scholar
  6. Kunchandy J, Kulkarni SK (1986) Reversal by alpha-2 agonists of diazepam withdrawal hyperactivity in rats. Psychopharmacology 90:198–202Google Scholar
  7. Lader M (1983) Dependence on benzodiazepines. J Clin Psychiatry 44:121–127Google Scholar
  8. Little HJ, Dolin S, Halsey MJ (1986) Calcium channel antagonists decrease the ethanol withdrawal syndrome. Life Sci 39:2059–2065Google Scholar
  9. Littleton JM, Little HJ (1988) Dihydropyridine-sensitive Ca++ channels in brain are involved in the central nervous system hyperexcitability associated with alcohol withdrawal states. Ann NY Acad Sci 522:199–202Google Scholar
  10. Mendelson WB, Skolnick P, Martin JV, Luu MD, Wagner R, Paul SM (1984) Diazepam stimulated increase in the synaptosomal uptake of45Ca2+:reversal by dihydropyridine calcium channel antagonists. Eur J Pharmacol 104:181–183Google Scholar
  11. Murphy SM, Owen RT, Tyrer PJ (1984). Withdrawal symptoms after six weeks treatment with diazepam. Lancet ii:1389Google Scholar
  12. Patch T, Little HJ, Siarey RJ, Dolin SJ (1989) Nitrendipine decrease seizure incidence during benzodiazepine withdrawal but not seizures caused by bicuculline. Br J Pharmacol 97:493PGoogle Scholar
  13. Ramakumar V, El-Fakahany EE (1988) Morphine treatment increases (3H) nimodipine binding sites in rat brain: attenuation by nimodipine and other Ca2+ channel antagonists of naloxoneprecipitated withdrawal in morphine dependent animals. Ann NY Acad Sci 522:207–209Google Scholar
  14. Rampe D, Triggle DJ (1986) Benzodiazepines and calcium channel function. TIPS 7:461–464Google Scholar
  15. Rickels K, Case G, Downing R, Winokur A (1983) Long term diazepam therapy and clinical outcome. JAMA 250:767–771Google Scholar
  16. Ryan G, Boisse NR (1983) Experimental induction of benzodiazepine tolerance and physical dependence. J Pharmacol Exp Ther 226:100–107Google Scholar
  17. Schatzki A, Lopez F, Greenblatt DJ, Shader RJ, Miller LG (1989) Lorazepam discontinuation promotes ‘inverse agonist’ effects of benzodiazepines. Br J Pharmacol 98:451–454Google Scholar
  18. Snedecor GW, Cochran WG (1967) Statistical methods. Iowa State University Press, Ames, IowaGoogle Scholar
  19. Swann AC, Elsworth JD, Charney DS, Jablons JW, Roth RH, Raymond DE, Maas JW (1982) Brain catecholamine metabolites and behaviour in morphine withdrawal. Eur J Pharmacol 86:167–175Google Scholar
  20. Tallman JF, Gallager DW (1985) The GABA-ergic system: a locus of benzodiazepine action. Annu Rev Neurosci 8:21–44Google Scholar
  21. Williams VC, Varnado GC, Nwangwu PU (1985). Clinical pharmacology of benzodiazepines. Drugs of Today 21:75–96Google Scholar

Copyright information

© Springer-Verlag 1992

Authors and Affiliations

  • Yati Chugh
    • 1
  • N. Saha
    • 1
  • A. Sankaranarayanan
    • 1
  • P. L. Sharma
    • 1
  1. 1.Department of PharmacologyPostgraduate Institute of Medical Education and ResearchChandigarhIndia

Personalised recommendations